Europe · Wires & real time · Reuters

Novo loses share in Brazil to cheaper generics, but holds up in Canada and India

Published by Reuters · United Kingdom 10 h ago

Novo ‌Nordisk is losing market share in Brazil after its semaglutide patent expired, driving a 3% decline in emerging market sales in the third quarter, CEO Mike Doustdar told…

Read the full article on Reuters Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026

Reuters Sustainable Business

Novo loses share in Brazil to cheaper generics, but holds up in Canada and India

Share

Also worth reading

Armenian security officers detain opposition leader Karapetyan

US trade deficit narrows to $105B in September as exports rise

Prediction markets get Democratic win right, with a few surprises

UK minister formally intervenes in Sky's £1.6 billion ITV deal

TAILG Showcases Long-Range Technology and a Versatile Product Lineup at EICMA 2026

Democratic sweep positive for US credit rating outlook, Scope Ratings says